Literature DB >> 498446

Role of the renin-angiotensin system in blood pressure regulation. The cardiovascular effects of converting enzyme inhibition in normotensive subjects.

A P Niarchos, T G Pickering, D B Case, P Sullivan, J H Laragh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 498446     DOI： 10.1161/01.res.45.6.829

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  8 in total

Review 1.  ACE inhibitors. Drug interactions of clinical significance.

Authors:  C Mignat; T Unger
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

2.  High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion.

Authors:  Caixia Li; Silas A Culver; Syed Quadri; Kelly L Ledford; Qusai Y Al-Share; Hilda E Ghadieh; Sonia M Najjar; Helmy M Siragy
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-09-15       Impact factor: 4.310

3.  Human lung angiotensin converting enzyme. Purification and antibody preparation.

Authors:  J Friedland; E Silverstein; M Drooker; C Setton
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

4.  Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.

Authors:  J A Millar; F H Derkx; K McLean; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

5.  A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.

Authors:  P J Manhem; S G Ball; J J Morton; G D Murray; B J Leckie; R Fraser; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

Review 6.  The clinical potential of renin inhibitors and angiotensin antagonists.

Authors:  R J Cody
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 7.  Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review.

Authors:  B Dahlöf
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 8.  Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.

Authors:  R J Cody
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.